We are a venture capital firm focused on the life science and medical device sectors.
Our mission is to invest in exceptional young companies that are able to deliver breakthrough medical advances.
Our investment strategy is focused primarily on direct secondary transactions, though we also make primary venture investments that complement our goals. As a secondary investor, we provide flexible liquidity solutions for other investors or corporations that wish to divest some or all of their investment assets or to access additional capital and resource to optimise investment outcomes. We bring new capital to the table to participate in follow-on financings and help support key programs through value-adding inflection points.
We are an experienced team that engages strategically with our portfolio company Boards, management teams and co-investors to help secure successful corporate partnerships, IPOs and trade sales.
Rosetta has raised five funds to date and is actively managing funds IV and V.